The proteins ATG16L1 and ATG3 are identified as critical to various stages of autophagy [38], suggesting that targeting the interactions among m6A modifications, autophagy, and ferroptosis may offer new avenues for the treatment of NB, potentially enhancing therapeutic outcomes. The gene discussed is ATG3; the disease is neuroblastoma.